发明名称 |
Biopolymer markers indicative of type II diabetes |
摘要 |
The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of at least one disease state relative to recognition of the presence and/or the absence of the biopolymer, predict disease risk assessment, and develop therapeutic avenues against the disease.
|
申请公布号 |
US7122327(B2) |
申请公布日期 |
2006.10.17 |
申请号 |
US20010993300 |
申请日期 |
2001.11.23 |
申请人 |
NANOGEN INC. |
发明人 |
JACKOWSKI GEORGE;MARSHALL JOHN |
分类号 |
G01N27/62;G01N33/567;A61K38/00;A61K45/00;A61P3/10;C07K14/47;C07K16/18;C12P21/08;G01N33/483;G01N33/53;G01N33/564;G01N33/68 |
主分类号 |
G01N27/62 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|